A clinical study assessing clinical outcomes and healthcare resource utilization (HCRU) of uncontrolled gout UG prior to pegloticase initiation
Latest Information Update: 01 Jul 2022
At a glance
- Drugs Pegloticase (Primary)
- Indications Gout
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Jul 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism